Michael Maroules, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1011 Clifton Ave, Clifton, NJ 07013 Phone: 862-591-2002 Fax: 862-591-2344 |
Dr. Richards Afonja, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 476 Colfax Ave, Clifton, NJ 07013 Phone: 973-594-7977 Fax: 973-594-9983 |
Azhagasundaram Ganesan, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 534 Clifton Ave, Clifton, NJ 07011 Phone: 976-365-1330 Fax: 973-365-2410 |
Dr. Aamir Zaman, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1035 Us Highway 46, Suite 202, Clifton, NJ 07013 Phone: 973-777-2212 Fax: 973-777-0469 |
Kyudong Peter Uhm, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1117 Us Highway 46, Suite 205, Clifton, NJ 07013 Phone: 973-471-0981 |
News Archive
A new analysis by Oregon State University researchers of California's mental health system finds that comprehensive, community-based mental health programs are helping people with serious mental illness transition to independent living.
The ongoing disruptive changes from efforts to reduce the spread of COVID-19 are having a substantial negative impact on the physical and mental well-being of parents and their children across the country, according to a new national survey published today in Pediatrics.
"As two people who worked as physicians in the early years of the HIV/AIDS epidemic before the miracle of antiretroviral drug (ARV) therapy, and who now have the honor of leading the domestic and global HIV/AIDS programs for the Obama administration, we look back in awe of the American leadership that has transformed the epidemic in the 22 years since the International AIDS Conference was last held on U.S. soil," Grant Colfax, director of the Office of National AIDS Policy, and U.S. Global AIDS Coordinator Ambassador Eric Goosby write in a Washington Blade opinion piece.
The high cost of prescription drugs is among consumers' top health policy issues, according to public opinion polls.
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, announced today that it has entered into a strategic agreement with Harlan Biotech Israel Ltd (HBI), a leading Good Laboratory Practice contractor, in order to complete pre-clinical safety experiments for the company's innovative therapy for ALS (Amyotrophic Lateral Sclerosis, also known as Lou Gehrig's disease).
› Verified 2 days ago